Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency

Alpha-1-antitrypsin deficiency (AATD) is a rare cause of noncystic fibrosis (CF) bronchiectasis. The benefits of augmentation therapy in patients with chronic obstructive pulmonary disease (COPD) and pulmonary emphysema are well established. The role of augmentation therapy in AATD bronchiectasis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Buck, Emanuel, Presotto, Maria Ada, Brock, Judith, Schlamp, Kai, Veith, Martina, Herth, Felix J.F., Trudzinski, Franziska Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489489/
https://www.ncbi.nlm.nih.gov/pubmed/36161236
http://dx.doi.org/10.1016/j.rmcr.2022.101740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489489/
https://www.ncbi.nlm.nih.gov/pubmed/36161236
http://dx.doi.org/10.1016/j.rmcr.2022.101740

Ejemplares similares